MAUDE MDR 6336950

MDR report key
6336950
Report number
1019632-2017-00004
Event key
0
Event type
3
Date of event
2017-02-10
Date received
2017-02-16
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
0
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Report source
D
Manufacturer link flag
N

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1LIFESTYLESNATURAL RUBBER LATEX CONDOMSURETEX PROPHYLACTICS (I), LTDHIS1601181922* R

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12017-02-1601. R

Event Narratives#

N

Patient 1

ON 02/16/2017 A FIRST REVIEW OF RELEASE RECORD INDICATES THAT THE DEVICE MET ALL SPECIFICATIONS FOR RELEASE. FURTHER EVALUATION ON GOING.

D

Patient 1

ON (B)(6) 2017 USER INDICATED THAT THEY RECEIVED PRODUCT FROM A PUBLIC HEALTH SERVICE ADMINISTERED BY THE STATE OF (B)(6). AFTER USING A LIFESTYLES ULTRA LUBRICATED LATEX CONDOM, THE USER EXPERIENCED CONTACT DERMATITIS REACTION. HE LATER WENT TO A DERMATOLOGIST WHO PROVIDED A TOPICAL OINTMENT TREATMENT. USER HAS COMMUNICATED THAT THEY WENT TO A ALLERGIST, CONDUCTED A PATCH TEST AND SHOWED ALLERGY TO ME-ISTHIAZOLINONE AND PARABENS BUT NOT LATEX ALLERGY; A COPY OF A REPORT HAS NOT BEEN PROVIDED TO ANSELL.

N

Patient 1

ON (B)(6) 2017 A FIRST REVIEW OF RELEASE RECORD INDICATES THAT THE DEVICE MET ALL SPECIFICATIONS FOR RELEASE. FURTHER EVALUATION ON GOING (B)(6) 2017 13 PCS OF SAME LOT PRODUCT WERE TESTED FOR MICROBIAL TESTING. RESULTS ARE ALL WITHIN REQUIRED SPECIFICATIONS. NO ASSIGNABLE CAUSE CAN BE FOUND FROM A REVIEW OF THE DHR AND INSPECTION OF RETAINED SAMPLES. NO FURTHER INVESTIGATION OR CORRECTION ACTION IDENTIFIED.

D

Patient 1

ON (B)(6) 2017 USER INDICATED THAT THEY RECEIVED PRODUCT FORM A PUBLIC HEALTH SERVICE ADMINISTERED BY THE STATE OF (B)(4). AFTER USING A LIFESTYLES ULTRA LUBRICATED LATEX CONDOM, THE USER EXPERIENCED CONTACT DERMATITIS REACTION. HE LATER WENT TO A DERMATOLOGIST WHO PROVIDED A TOPICAL OINTMENT TREATMENT. USER HAS COMMUNICATED THAT THEY WENT TO A ALLERGIST, CONDUCTED A PATCH TEST AND SHOWED ALLERGY TO ME-ISTHIAZOLINONE AND PARABENS BUT NOT LATEX ALLERGY; A COPY OF A REPORT HAS NOT BEEN PROVIDED TO ANSELL.

N

Patient 1

ON 02/16/2017 A FIRST REVIEW OF RELEASE RECORD INDICATES THAT THE DEVICE MET ALL SPECIFICATIONS FOR RELEASE. FURTHER EVALUATION ON GOING. ON 2/21/2017 13 PCS OF SAME LOT PRODUCT WERE TESTED FOR MICROBIAL TESTING. RESULTS ARE ALL WITHIN REQUIRED SPECIFICATIONS. NO ASSIGNABLE CAUSE CAN BE FOUND FROM A REVIEW OF THE DHR AND INSPECTION OF RETAINED SAMPLES. NO FURTHER INVESTIGATION OR CORRECTION ACTION IDENTIFIED ON 03/30/2017 RETAIN SAMPLES WENT THROUGH MICROBIAL TESTING; RESULTS WERE WITHIN SPECIFICATION. CUSTOMER SAMPLES WERE RECEIVED AND SENT FOR MICROBIAL TESTING; RESULTS WERE WITHIN SPECIFICATION. NO OTHER ACTION TO BE TAKEN AT THIS TIME.

D

Patient 1

ON 02/16/2017 USER INDICATED THAT THEY RECEIVED PRODUCT FORM A PUBLIC HEALTH SERVICE ADMINISTERED BY THE STATE OF (B)(4). AFTER USING A LIFESTYLES ULTRA LUBRICATED LATEX CONDOM, THE USER EXPERIENCED CONTACT DERMATITIS REACTION. HE LATER WENT TO A DERMATOLOGIST WHO PROVIDED A TOPICAL OINTMENT TREATMENT. USER HAS COMMUNICATED THAT THEY WENT TO A ALLERGIST, CONDUCTED A PATCH TEST AND SHOWED ALLERGY TO ME-ISOTHIAZOLINONE AND PARABENS BUT NOT LATEX ALLERGY; A COPY OF A REPORT HAS NOT BEEN PROVIDED TO ANSELL.